Sections

Alphabetical list:

A B C D E F G H I J K L M N O P R S T U V W X Y Q Z 1 2 3 4 5 6 7 8 9

News: December 12, 2009

Researchers Find New Drug To Shrink Breast Cancer Tumors

December 12, 2009

Boston (SmartAboutHealth) - Researchers have discovered a new antibody drug that has the ability to shrink breast cancer tumors that other drugs have failed to impact.
The study was carried out by researcher Dr. Ian Krop and colleagues at the Dana Farber Cancer Institute.
What they discovered is that a hybrid drug, T-DM1, was able to shrink or at least stop the growth of HER2-positive breast cancer tumors.
The drug is a combination of the antibody tratuzumab and the drug DM1, which has the ability to kill breast cancer cells.
The way in which the drug works is pretty remarkable, as it has the ability to cling onto and attack only breast cancer cells, not the healthy cells in the body.
The antibody can work in conjunction with chemotherapy, allowing the chemotherapy to work while not harming the rest of the body.
During the study, they found that the drug was effective in treating 40% of women who have the HER2-positive breast cancers.
The tumors were shrunk by a margin of 30% or more when it was used.
The drug was also found to stabilize the breast cancer tumors at a high rate as well.
The new drug was presented at the 32nd annual CTRC-AACR San Antonio Breast Cancer Symposium.


Archive issues: (50)

Archive list: 1 2 3 4 5 6 7 8 9 10 11 12 [13] 14 15 16 17

November 8, 2009 | American Diabetes Association Launches Campaign to "Stop Diabetes"

How much do you know about diabetes? Many Americans do not know much about this disease that strikes someone every 20 seconds in the United States. That is one reason why the American Diabetes Association (ADA) has launched its "Stop Diabetes" campaign as part of American Diabetes Month.  According to the results of a survey conducted ...

November 7, 2009 | Strong Immune Response by Healthy Pregnant Women to H1N1 Vaccine

An ongoing clinical trial finds that healthy pregnant women have a strong immune response after receiving just one dose of H1N1 influenza vaccine. The trial, which began on September 9, is sponsored by the National Institute of Allergy and Infectious Disease ...

November 6, 2009 | Salt and diet soda can both take a toll on kidneys

Research from Brigham and Women's Hospital shows that salt and diet soda can take a toll on our kidneys. Consuming a high salt diet and artificially sweetened drinks was linked to greater kidney function declines over an eleven year period.  Women participating in the Nurses' Health Study were examined to find the association between diet soda and salt on kidney function decline, and included 3000 ...

Archive list: 1 2 3 4 5 6 7 8 9 10 11 12 [13] 14 15 16 17

Related articles:

Independence and invulnerability

  Men are significantly less likely to visit their physicians to receive preventive health care examinations. Men make 134.5 million less physician visits than American women each year - making only 40.8% of all physician visits. A quarter of the men who are 45 to 60 do not have a personal physician. Men fail to make advised annual heart checkups. Men between 25 and 65 are four times more likely to die from cardiovascular disease than women.  Men are ...

Section: Mens health risks

Chronic prostatitis/chronic pelvic pain syndrome - signs and symptoms

  Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is characterised by pelvic or perineal pain without evidence of urinary tract infection, lasting longer than 3 months, as the key symptom. Symptoms may wax and wane. Pain can range from mild discomfort to debilitating. Pain may radiate to back and rectum, making sitting difficult. Dysuria, arthralgia, myalgia, unexplained fatigue, abdominal pain, constant burning pain in the penis, and frequency may all be present. Frequent urination and increased urgency may suggest interstitial cystitis (inflammation ...

Section: Prostatitis

Alprostadil

  Alprostadil can be injected into the penis or inserted using a special applicator - usually just before sexual intercourse. Alprostadil has also become available in some countries as a topical cream (under the brand name Befar), and preliminary studies have shown a clinical efficacy of up to 83%. It has an onset of action of 10-15 minutes and its effects can last over 4 hours.    

Section: Erectile Dysfunction

News

December 20, 2009

Wii, Xbox 360 and Other Video Games Offer Some Benefits

Wii, Xbox 360, PlayStation, and other video games are hot on holiday gift lists, but some parents wonder whether these games offer any benefits or are detrimental to kids. The results of a new study may put some minds at ease, while others may ...

December 18, 2009

Should You Be Shoveling Snow?

Yes, the weather outside is frightful, and soon you will have to think about shoveling snow. But should you be the one doing the work? Who should and should not shovel snow, and how can you do it safely?  Every winter, approximately 1,200 Americans die from a ...

December 17, 2009

Athletes who take NSAID's to prevent pain may be doing more harm than good

According to Stuart Warden, a researcher who studies musculoskeletal health and sports medicine, athletes who ritualistically take NSAID's to prevent post event and workout soreness and inflammation may be depriving the body of healing, in addition to risking other long term health problems. Taking anti inflammatory medications before running or other ...

Blogroll